IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Provided By GlobeNewswire
Last update: Aug 29, 2024
NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and co-founder, will be presenting at the:
0.1534
+0.01 (+8.03%)
Find more stocks in the Stock Screener
INAB Latest News and Analysis
3 days ago - ChartmillThese stocks are moving in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
